Xeris Biopharma Holdings, Inc. (XERS) Revenue & EPS Growth Rates 2026 | EvidInvest

Growth Analysis - XERS

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth43.72%

5Y CAGR42.54%

10Y CAGRN/A

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth-19.82%

5Y CAGR-8.50%

10Y CAGRN/A

Equity

1Y GrowthN/A

5Y CAGR-32.15%

10Y CAGRN/A

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	43.7%	33.4%	38.3%	42.5%	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	23.9%	35.7%	60.0%	58.7%	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	48.7%	81.8%	49.0%	131.5%	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	122.3%	49.1%	76.2%	134.5%	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	0.0%	56.9%	172.0%	115.2%	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	146.0%	348.5%	217.1%	N/A	N/A	N/A	N/A	N/A
FY 2019 Dec 31, 2019	717.6%	259.9%	165.7%	N/A	N/A	N/A	N/A	N/A
FY 2018 Dec 31, 2018	58.4%	51.4%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2017 Dec 31, 2017	44.7%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2016 Dec 31, 2016	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - XERS

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Xeris Biopharma Holdings, Inc.

Compare with peers

Explore

Growth Analysis - XERS

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Xeris Biopharma Holdings, Inc.

Compare with peers

Explore